Related Experiment Video
Updated: Aug 8, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Mitogen-activated protein kinase phosphorylates and targets inducible cAMP early repressor to ubiquitin-mediated
G Yehia1, F Schlotter, R Razavi
1Department of Obstetrics, Gynecology and Women's Health, New Jersey Medical School, Newark, New Jersey 07103, USA.
Abstract:
Inducible cAMP early repressor (ICER) is an important mediator of cAMP antiproliferative activity that acts as a putative tumor suppressor gene product. In this study, we examined the regulation of ICER protein by phosphorylation and ubiquitination in human choriocarcinoma JEG-3 and mouse pituitary AtT20 cells. We found that cAMP stabilized ICER protein by inhibiting the mitogen-activated protein kinase (MAPK) cascade. Activation of the MAPK pathway increased ICER phosphorylation. ICER phosphorylation was abrogated by inhibition of the MAPK pathway either by cAMP or directly by the MAPK inhibitor PD098059. The MAPKs extracellular signal-regulated kinases 1 and 2 physically interact with ICER and mediated the phosphorylation of ICER on a critical serine residue (Ser-41). A mutant form of ICER in which Ser-41 was substituted by alanine had a half-life 4-5 h longer than its wild-type counterpart. This alteration in stability was due to the inability of the Ser-41-mutant ICER to be efficiently ubiquitinated and degraded via the ubiquitin-proteasome pathway. These results present a novel cell signaling cross-talk mechanism at the cell nucleus between the MAPK and cAMP pathways, whereby MAPK targets a repressor of the cAMP-dependent gene expression for ubiquitination and proteasomal degradation.
Insights
Cyclic AMP (cAMP) stabilizes the ICER protein by inhibiting the MAPK pathway, preventing its phosphorylation, ubiquitination, and degradation. This uncovers a novel signaling cross-talk mechanism regulating gene expression.
Area of Science:
- Cellular signaling
- Molecular biology
- Cancer research
Background:
- Inducible cAMP early repressor (ICER) mediates cAMP's antiproliferative effects and acts as a tumor suppressor.
- Regulation of ICER protein stability is crucial for understanding its cellular functions.
Purpose of the Study:
- To investigate the regulation of ICER protein stability by phosphorylation and ubiquitination.
- To elucidate the interplay between cAMP and MAPK signaling pathways in controlling ICER levels.
Main Methods:
- Experiments were conducted in human choriocarcinoma JEG-3 and mouse pituitary AtT20 cells.
- Investigated ICER phosphorylation and ubiquitination in response to cAMP and MAPK pathway modulation.
- Utilized a mutant ICER form (Ser-41 to alanine) to assess the role of specific phosphorylation sites.
Main Results:
- cAMP stabilizes ICER by inhibiting the MAPK cascade, thereby reducing ICER phosphorylation.
- Extracellular signal-regulated kinases 1 and 2 (MAPKs) directly phosphorylate ICER at Ser-41.
- Phosphorylation at Ser-41 targets ICER for ubiquitination and proteasomal degradation; a non-phosphorylatable mutant exhibits increased stability.
Conclusions:
- A novel cross-talk mechanism exists between MAPK and cAMP pathways in the nucleus.
- MAPK signaling promotes ICER degradation via ubiquitination and proteasomal pathways.
- This regulation impacts cAMP-dependent gene expression and ICER's role as a tumor suppressor.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Anaphase Promoting Complex
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways

